BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23371797)

  • 1. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer.
    Barney BJ; Wang XS; Lu C; Liao Z; Johnson VE; Cleeland CS; Mendoza TR
    Qual Life Res; 2013 Oct; 22(8):2143-50. PubMed ID: 23371797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
    Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
    Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer.
    Shi Q; Mendoza TR; Wang XS; Cleeland CS
    Eur J Cancer; 2016 Nov; 67():83-90. PubMed ID: 27620946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.
    Fagundes CP; Shi Q; Vaporciyan AA; Rice DC; Popat KU; Cleeland CS; Wang XS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):613-9.e2. PubMed ID: 26088408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness and prognostic value of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in assessment of lung cancer patients.
    Bircan HA; Yalcin GS; Fidanci S; Karaibrahimoglu A; Tuglu HC
    Support Care Cancer; 2020 Apr; 28(4):2005-2014. PubMed ID: 31388746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determinants of health-related quality of life among patients with newly diagnosed lung cancer in Taiwan: A cross-sectional study.
    Liao CH; Yu S; Lin KC; Wu YC; Wang TJ; Wang KY
    J Chin Med Assoc; 2023 Mar; 86(3):338-344. PubMed ID: 36730003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
    Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
    Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter?
    Efficace F; Cartoni C; Niscola P; Tendas A; Meloni E; Scaramucci L; Soldati S; Brunetti GA; Marini MG; Mandelli F
    Eur J Haematol; 2012 Nov; 89(5):410-6. PubMed ID: 22985353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
    Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
    Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer.
    Whisenant MS; Williams LA; Garcia Gonzalez A; Mendoza T; Shi Q; Cleeland C; Zhang J; Heymach J; Simon G
    JCO Oncol Pract; 2020 Oct; 16(10):e1151-e1160. PubMed ID: 32539654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.
    Meyer LA; Nick AM; Shi Q; Wang XS; Williams L; Brock T; Iniesta MD; Rangel K; Lu KH; Ramirez PT
    Gynecol Oncol; 2015 Mar; 136(3):440-5. PubMed ID: 25647455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory-Spine Tumor Module.
    Xu N; Li Z; Wei F; Liu X; Jiang L; Meng N; Jiang P; Yu M; Wu F; Dang L; Zhou H; Li Y; Liu Z
    J Pain Symptom Manage; 2017 Mar; 53(3):605-613. PubMed ID: 28042067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
    Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
    J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms in the general Norwegian adult population - prevalence and associated factors.
    Krogstad H; Loge JH; Grotmol KS; Kaasa S; Kiserud CE; Salvesen Ø; Hjermstad MJ
    BMC Public Health; 2020 Jun; 20(1):988. PubMed ID: 32576168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysis.
    Soh SE; Morello R; Ayton D; Ahern S; Scarborough R; Zammit C; Brand M; Stirling RG; Zalcberg J
    Health Qual Life Outcomes; 2021 May; 19(1):157. PubMed ID: 34059079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
    Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
    J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.